Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

TALIS BIOMEDICAL CORPORATION

(TLIS)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť TALIS BIOMEDICAL CORPORATION
18/01SHAREHOLDER ALERT : Robbins LLP Reminds Investors that Talis Biomedical Corporation (TLIS)..
BU
18/01SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis..
PR
12/01SHAREHOLDER ALERT : Robbins LLP Informs Investors that Talis Biomedical Corporation (TLIS)..
BU
12/01TLIS INVESTOR ALERT : Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical..
PR
07/01SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis..
PR
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis..
PR
2021TALIS BIOMEDICAL CORP : Change in Directors or Principal Officers, Financial Statements an..
AQ
2021INVESTOR ALERT : Law Offices of Howard G. Smith Continues Its Investigation of Talis Biome..
BU
2021The Law Offices of Frank R. Cruz Continues Its Investigation of Talis Biomedical Corpor..
BU
2021Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investi..
BU
2021Talis Biomedical Announces Leadership Transition
AQ
2021The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporatio..
PR
2021INVESTOR ALERT : Law Offices of Howard G. Smith Continues Its Investigation of Talis Biome..
PR
2021Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investi..
PR
2021Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2021TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and ..
AQ
2021TALIS BIOMEDICAL : Announces Third Quarter 2021 Financial Results and Business Progress - ..
PU
2021TALIS : Q3 Earnings Snapshot
AQ
2021TALIS BIOMEDICAL CORP : Results of Operations and Financial Condition, Change in Directors..
AQ
2021Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
GL
2021Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
GL
2021Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Of..
AQ
2021Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular P..
PU
2021TALIS BIOMEDICAL CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular P..
AQ
2021Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021
AQ
2021GLANCY PRONGAY & MURRAY LLP : a National Class Action Law Firm, Continues Investigation of..
BU
2021INVESTOR ALERT : Law Offices of Howard G. Smith Continues Investigation of Talis Biomedica..
BU
2021TALIS ALERT : Bragar Eagel & Squire, P.C. is Investigating Talis on Behalf of Talis Stockh..
BU
2021GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Continues Investigation of Talis Biomedical Corporation..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Talis Biomedical Corporation..
BU
2021TALIS BIOMEDICAL : Announces CEO Transition (Form 8-K)
PU
2021TALIS BIOMEDICAL CORP : Change in Directors or Principal Officers, Financial Statements an..
AQ
2021TALIS BIOMEDICAL : Announces CEO Transition
AQ
2021TALIS : Q2 Earnings Snapshot
AQ
2021TALIS BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021TALIS BIOMEDICAL : Announces Second Quarter 2021 Financial Results and Business Progress (..
PU
2021TALIS BIOMEDICAL : Announces Second Quarter 2021 Financial Results and Business Progress
AQ
2021TALIS BIOMEDICAL : to Announce Second Quarter 2021 Financial Results on August 10, 2021
AQ
2021TALIS BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021TALIS : Q1 Earnings Snapshot
AQ
2021Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress
GL
2021TALIS BIOMEDICAL : Announces First Quarter 2021 Financial Results and Business Progress (F..
PU
2021TALIS BIOMEDICAL : to Announce First Quarter 2021 Financial Results on May 11, 2021
AQ
2021TALIS BIOMEDICAL : to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conf..
AQ
2021TALIS BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021TALIS BIOMEDICAL CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2021Talis Appoints Jeryl Hilleman to Board of Directors
GL
2021TALIS BIOMEDICAL CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021TALIS BIOMEDICAL : Provides Update on Regulatory Pathway for Emergency Use Authorization (..
AQ
2021TALIS BIOMEDICAL CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, O..
AQ
2021Talis Announces Closing of Initial Public Offering and Full Exercise of Underwriters' O..
GL
2021Talis Announces Pricing of Initial Public Offering
GL
Volgende evenement op TALIS BIOMEDICAL CORPORATION
10/05/22
Komende gebeurtenissen in de sector